FTD Unit Boston

The MGH Frontotemporal Disorders (FTD) Unit is a leading clinical-research facility dedicated to understanding and treating Frontotemporal Degeneration (FTD) and its related disorders, such as Primary Progressive Aphasia, Semantic Dementia, and Progressive Supranuclear Palsy. Located in Boston, Massachusetts, this unit focuses on enhancing diagnosis and treatment options for various forms of dementia, including young-onset and atypical Alzheimer's disease.

The MGH FTD Unit provides a wide range of clinical services, including diagnostic assessments, second opinions, treatment recommendations, and ongoing patient monitoring. They collaborate closely with prominent hospitals and research centers, such as Brigham & Women’s Hospital and the Association for FTD, ensuring comprehensive care. Additionally, specialized services in areas like genetic counseling, occupational therapy, and neuropsychological assessment are available.

Supported by various funding sources, including the National Institutes of Health, the MGH FTD Unit is committed to advancing knowledge and offering educational opportunities for patients and families affected by these complex disorders.